Bayer

Upcoming events – Bayer and Merck look to vericiguat, and Akero bets on Nash
Upcoming events – Bayer and Merck look to vericiguat, and Akero bets on Nash
EP Vantage
Bayer
Merck
vericiguat
heart failure
AKR-001
Akero Therapeutics
clinical trials
NASH
Flag link:
Who are the 10 Most Innovative Biopharma Companies?
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
innovation
Regeneron
Verily
Illumina
Biogen
Bayer
Bluebird Bio
Novartis
GSK
Genentech
Amgen
Flag link:
Tumour-agnostic drugs ‘game-changing’, says NICE as it rejects one from Bayer
Tumour-agnostic drugs ‘game-changing’, says NICE as it rejects one from Bayer
Pharmaforum
cancer
UK
NICE
Bayer
Vitrakvi
drug pricing
Flag link:
Bayer to commercialize Daré’s monthly contraceptive Ovaprene in US
Bayer to commercialize Daré’s monthly contraceptive Ovaprene in US
Pharmaceutical Business Review
Bayer
Daré Bioscience
Ovaprene
contraceptives
Flag link:
FDA Update: Ongoing Essure Surveillance
FDA Update: Ongoing Essure Surveillance
Medical Devices and Diagnostics Industry
Bayer
Essure
devices
contraceptives
Flag link:
After AstraZeneca, Sanofi deals, Schrödinger teams with Bayer to speed up drug work
After AstraZeneca, Sanofi deals, Schrödinger teams with Bayer to speed up drug work
Fierce Biotech
Schrödinger
Bayer
drug discovery
Flag link:
Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer
Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer
Endpoints
Roche
Tecentriq
Avastin
liver cancer
China
Bayer
Nexavar
clinical trials
Flag link:
Novartis, Bayer, Longwood back genomics startup to speed search for immunotherapy targets
Novartis, Bayer, Longwood back genomics startup to speed search for immunotherapy targets
Endpoints
Novartis
Bayer
Longwood
immunotherapy
genomics
immuno-oncology
Flag link:
Top 10 pharma settlements since 2018
Top 10 pharma settlements since 2018
Fierce Pharma
settlements
Reckitt Benckiser
JNJ
Bayer
Allergan
Actelion
Purdue Pharma
Teva Pharmaceutical
Endo
Teikoku
Insys
Pfizer
GSK
Astellas
Amgen
Flag link:
Merck and Bayer's heart drug meets main goal of late-stage study
Merck and Bayer's heart drug meets main goal of late-stage study
Yahoo/Reuters
Merck
Bayer
vericiguat
HFrEF
Flag link:
Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology
Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology
Xconomy
Bayer
Dewpoint Therapeutics
R&D
Flag link:
That $335M JV Bayer set up on CRISPR/Cas9? They’re letting the biotech partner carry on
That $335M JV Bayer set up on CRISPR/Cas9? They’re letting the biotech partner carry on
Endpoints
Bayer
CRISPR Therapeutics
CRISPR-Cas9
Flag link:
Which big pharma firms are best at digital?
Which big pharma firms are best at digital?
Pharmaforum
digital pharma
Bayer
Pfizer
Boehringer Ingelheim
Flag link:
Bayer chooses UK for its AI-focused R&D hub
Bayer chooses UK for its AI-focused R&D hub
Pharmaforum
Bayer
R&D
artificial intelligence
UK
Flag link:
Partner Bayer pushes Ionis' antithrombotic drug into mid-stage development
Partner Bayer pushes Ionis' antithrombotic drug into mid-stage development
Endpoints
Bayer
Ionis Pharmaceuticals
Factor XI
anti-thrombotics
clinical trials
IONIS-FXI-LR
Flag link:
Novartis’ new eye drug undercuts Bayer’s rival with fewer injections
Novartis’ new eye drug undercuts Bayer’s rival with fewer injections
Pharmaforum
Novartis
brolucizumab
Bayer
Eylea
wet age-related macular degeneration
FDA
Flag link:
Recent Job Cuts in the Biopharma Industry
Recent Job Cuts in the Biopharma Industry
BioSpace
Tocagen
Sanofi
Amneal
Daiichi Sankyo
Integra Life Sciences
Aclaris
Bayer
Novartis
Illumina
Merck
Roche Molecular Systems
Prometheus Labs
layoffs
Flag link:
Judge Dismisses ‘White Coat’ Whistleblower Allegations Against Bayer, Eli Lilly
Judge Dismisses ‘White Coat’ Whistleblower Allegations Against Bayer, Eli Lilly
BioSpace
Bayer
Eli Lilly
Humalong
Humulin
diabetes
whistleblower lawsuits
Flag link:
Bayer, Boston academics form joint lab to research lung disease
Bayer, Boston academics form joint lab to research lung disease
Fierce Biotech
Bayer
Brigham and Women's
Massachusetts General Hospital
lung disease
R&D
Flag link:
Bayer’s Vitrakvi is first tumour-agnostic drug approved in EU
Bayer’s Vitrakvi is first tumour-agnostic drug approved in EU
Pharmaforum
Bayer
TRK inhibitors
Vitrakvi
Europe
tumor agnostic drugs
cancer
Flag link:

Pages